(亜)急性期大動脈解離に対するTEVAR

抄録

Widespread use of thoracic aortic stent-graft placement as treatment for aortic aneurysms has recently been started, and its indication has expanded to include treatment of aortic dissection after the efficacy of TEVAR was proven. Furthermore, domestic approval and health insurance coverage have increased the use of TEVAR for aortic dissection. The indications for TEVAR do not classically include complicated type B aortic dissection, but they do include uncomplicated cases with a high risk of aneurysmal formation or other aortic events. Technical development of TEVAR including PETTICOAT technique etc. has also occurred. The basics and an update about TEVAR for acute or subacute aortic dissection are presented.